Use of sodium-glucose co-transporter 2 (SGLT2) inhibitors appears to significantly lower the risk of serious renal events as compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, according to a study.
Engaging in leisure-time physical activity (LTPA) more frequently leads to a lower incidence of severe diabetic retinopathy in individuals with type 1 diabetes (T1D), and this association is independent of activity intensity or duration per single session, according to data from the Finnish diabetic nephropathy (FinnDiane) study.
The antiresorptive agent denosumab, used alone or in combination with the calcimimetic agent cinacalcet, improves BMD and reduces bone turnover in patients with primary hyperparathyroidism (PHPT) — providing a potential treatment option for patients in whom surgery is undesirable, the DENOCINA* trials has shown.
In older adults with type 2 diabetes mellitus (T2DM), glucose control appears to influence survival such that both high and low glycated haemoglobin values are associated with increased risk of all-cause mortality, as shown in a study from Hong Kong. More importantly, very low HbA1c levels (<6.0 percent) pose the highest risk increase.